Session 2: Compound Management's Added Value

Chair: Olivier Casamitjana (Evotec)

The main objective of this session is to present concrete examples of how compound management adds value to scientific project plans. Examples will include the inclusion of specific workflows, equipment (innovation), additional resources and expertise, or adapting timelines to improve a scientific project overall.

Speakers:

Andrew Brierley (AstraZeneca)

Fabrice Turlais, Ph.D. (Evotec)

Evolution of Roche Compound Logistics to Support Compound Design Cycles and New Business Models
Nicolas Zorn, Ph.D. (Roche)

Additional abstract information will be updated soon.